With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Abacus Exchange and Barna Management School introduce summer programs May 24, 2022
- The Bodin’s : who is the woman of Jean-Christian Fraiscinet, Christèle Chappat ? May 12, 2020
- Floods kill at least 21 people in China’s Hubei province Aug 13, 2021
- “Do you want me to speak Argentine?”: Danna Paola surprised with her accent in a live broadcast Sep 22, 2020
- They today – María Emma Mejía: “In Colombia we had to advance in a gender policy much earlier” Oct 9, 2021
- Lyon: The Fourvière tunnel briefly blocked by environmental activists sitting on the traffic lanes Nov 25, 2022
- Putin spoke about his reaction to the amendment of a student in a conversation about the Northern War Sep 3, 2021